In other cancers, its role is context-dependent: GABARAP promotes tumor aggressiveness and poor survival in colorectal carcinoma (56), whereas in breast cancer it restrains epithelial-mesenchymal transition and invasion (57). Here, GABARAP is linked to breast cancer.